Canopy Growth Reports Strong Sales Growth While Battling a Governance Crisis
Published on 06/18/2026 at 17:47 | Redaktion boerse-global.de
The cannabis producer’s fourth-quarter performance tells two starkly different stories. On one side, revenue climbed to 71.2 million Canadian dollars, the balance sheet flipped from net debt to net cash, and market share inched up in Canada. On the other, the company’s CEO and CFO have been hit with a trading ban by the Ontario Securities Commission after a serious internal control failure forced a restatement of two years of financial results.
The regulatory action stems from the misclassification of US dollar-denominated warrants, which should have been booked as liabilities rather than equity because Canopy’s functional currency is the Canadian dollar. The error required the restatement of results for fiscal 2024 and 2025, plus several quarters from 2023 through 2025. Management insists the mistake was non-cash and had no impact on revenue, gross margin, operating cash flow or liquidity. The covenants on the company’s debt remained intact. Nonetheless, a material weakness in internal financial controls — disclosed in the annual report for the period ended March 31, 2026 — has rattled institutional confidence.
Operationally, the numbers offer a brighter picture. Net revenue for the fourth quarter of fiscal 2026 rose 10% year-over-year to 71.2 million Canadian dollars, with the cannabis segment jumping 20% to 54.5 million. Canadian medical cannabis was a standout, climbing 27% to 25.3 million, driven by an expanding base of insured patients. International medical cannabis surged 68%. On the recreational side, Canopy gained two spots in Canadian market share data from May 2026, moving from eighth to sixth place. For the full fiscal year, consolidated net revenue increased 6% to 284.6 million, while cannabis revenue rose 15%.
Should investors sell immediately? Or is it worth buying Canopy Growth?
The bottom line remains deep in the red. The net loss from continuing operations in Q4 reached 154.7 million Canadian dollars, or 0.17 per share, missing analyst consensus. Full-year net loss stood at 262.9 million. Still, the adjusted EBITDA loss narrowed sharply — from 9.2 million to 6.3 million in the quarter, and from 23.5 million to 20.2 million for the full year. Management is targeting positive adjusted EBITDA in fiscal 2027, and the recently closed acquisition of MTL Cannabis has already delivered 6 million of the 10 million in annual synergies targeted.
The balance sheet has been transformed. Canopy closed the fiscal year with 365 million Canadian dollars in cash and 234 million in total debt, yielding a net cash position of 131 million — a dramatic swing from a net debt position of 173 million a year earlier. Free cash outflow in Q4 shrank 61% to 69.1 million. CEO Luc Mongeau called fiscal 2026 a “pivotal year,” noting the company had streamlined its cost structure and reallocated resources toward higher-growth areas.
The stock, however, remains under severe pressure. At 0.84 euro on the German exchange, the shares are roughly 58% below the 52-week high of 2.00 euro reached in December 2025. Year-to-date losses stand at about 18%. The relative strength index of 37.9 suggests oversold conditions, but no clear reversal has materialized. The stock trades below both its 50-day and 200-day moving averages.
For investors, the next catalyst will be the first-quarter report for fiscal 2027, due around autumn 2026. To sustain a recovery, Canopy must prove that its operational momentum can continue while it simultaneously cleans up the governance mess. The OSC trading ban — and the underlying control weakness that triggered it — will be a difficult overhang to shake.
Ad
Canopy Growth Stock: New Analysis - 18 June
Fresh Canopy Growth information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
